Noel J. Cusack, Ph.D.

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Cusack NJ, Hourani SM. (2000) Platelet P2 receptors: from curiosity to clinical targets. Journal of the Autonomic Nervous System. 81: 37-43
Hourani SMO, Welford LA, Cusack NJ. (1996) Effects of 2-methylthioadenosine 5'-β,γ-methylenetriphosphonate and 2-ethylthioadenosine 5'-monophosphate on human platelet activation induced by adenosine 5'-diphosphate Drug Development Research. 38: 12-23
Cusack NJ, Pettey CJ. (1996) Effects of phosphate-modified analogs of adenosine 5'-diphosphate and adenosine 5'-triphosphate at P(2T)-purinoceptors mediating human platelet activation by ADP Drug Development Research. 37: 212-222
Hourani SM, Cusack NJ. (1991) Pharmacological receptors on blood platelets. Pharmacological Reviews. 43: 243-98
Cusack NJ, Hourani SMO. (1991) Design, syntheses and pharmacology of ATP analogues selective for subtypes of P2-purinoceptors Nucleosides and Nucleotides. 10: 1019-1028
Cusack NJ, Hourani SM. (1990) Subtypes of P2-purinoceptors. Studies using analogues of ATP. Annals of the New York Academy of Sciences. 603: 172-81
Born GV, Shafi S, Cusack NJ. (1990) Determinants of the atherogenic flux of low-density lipoprotein into arteries. Arzneimittel-Forschung. 40: 354-6
Born GV, Shafi S, Cusack NJ. (1989) Evidence for the acceleration of atherogenesis by circulating norepinephrine. Transplantation Proceedings. 21: 3660-1
Stone TW, Cusack NJ. (1989) Absence of P2-purinoceptors in hippocampal pathways. British Journal of Pharmacology. 97: 631-5
Agarwal AK, Tandon NN, Greco NJ, et al. (1989) Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation. Thrombosis and Haemostasis. 62: 1103-6